Patients in moderate-risk C3 (anti-S1-IgGhighestTlowestBmodNKmodIL-6mod) had 5.24 times higher hazard of death due to COVID-19 (95% CI 1.34–20.48 p=0.02) than patients in C5. This evidence concerns the gene PSMD1 and COVID-19.